Literature DB >> 23435409

Novel evidence of phenotypical variability in the hexanucleotide repeat expansion in chromosome 9.

Chiara Cerami1, Alessandra Marcone, Daniela Galimberti, Michele Zamboni, Chiara Fenoglio, Maria Serpente, Elio Scarpini, Stefano F Cappa.   

Abstract

C9ORF72 repeat expansion is currently considered as a major genetic cause of amyotrophic lateral sclerosis (ALS) and, in particular, of combined frontotemporal dementia-motor neuron disorder (FTD-MND) pedigrees. Studies of large series of patients have indicated that various phenotypic presentations may be observed even in the same family. Here, we describe four patients carrying a C9ORF72 mutation with heterogeneous clinical presentation sharing a rapid disease course. Cases #1 and #2 presented with predominant semantic deficits, accompanied in one patient by clinical signs of ALS. Case #3 showed a phenotype compatible with a diagnosis of behavioral variant of FTD. Case #4 presented with memory impairments, apathy, and social withdrawal, and had negative cerebrospinal fluid markers for Alzheimer's disease. Two patients showed a positive familiar history of MND and dementia (at least one first-degree family member affected). The two other patients were apparently sporadic cases. Our data provide further evidence for the heterogeneity of phenotypes associated with the C9ORF72 mutation and indicate its association with a fluent progressive aphasia phenotype. The present findings confirm the importance of screening for the hexanucleotide repeat expansion in chromosome 9 in the case not only of familial, but also of sporadic FTD, and in the presence of atypical cognitive disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23435409     DOI: 10.3233/JAD-122302

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  4 in total

1.  Genetic screen in a large series of patients with primary progressive aphasia.

Authors:  Eliana Marisa Ramos; Deepika Reddy Dokuru; Victoria Van Berlo; Kevin Wojta; Qing Wang; Alden Y Huang; Zachary A Miller; Anna M Karydas; Eileen H Bigio; Emily Rogalski; Sandra Weintraub; Benjamin Rader; Bruce L Miller; Maria Luisa Gorno-Tempini; Marek-Marsel Mesulam; Giovanni Coppola
Journal:  Alzheimers Dement       Date:  2019-01-25       Impact factor: 21.566

Review 2.  Interactions of pathological proteins in neurodegenerative diseases.

Authors:  Tara L Spires-Jones; Johannes Attems; Dietmar Rudolf Thal
Journal:  Acta Neuropathol       Date:  2017-04-11       Impact factor: 17.088

Review 3.  Primary progressive aphasia and motor neuron disease: A review.

Authors:  Edoardo Nicolò Aiello; Sarah Feroldi; Giulia De Luca; Lucilla Guidotti; Eleonora Arrigoni; Ildebrando Appollonio; Federica Solca; Laura Carelli; Barbara Poletti; Federico Verde; Vincenzo Silani; Nicola Ticozzi
Journal:  Front Aging Neurosci       Date:  2022-09-08       Impact factor: 5.702

Review 4.  The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype.

Authors:  Johnathan Cooper-Knock; Pamela J Shaw; Janine Kirby
Journal:  Acta Neuropathol       Date:  2014-02-04       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.